New Study Opportunity at Joslin Diabetes Center
About the study If you’re 16 years or older and were diagnosed with type 1 diabetes within the past 12…
Take Action: Tell the FDA Your Thoughts on Sotagliflozin
New T1D Equity Framework Partnership with Medtronic Inc.
CDC Adds T1D as Medical Condition Associated with Higher Risk for Severe COVID-19
The Centers for Disease Control (CDC) has added type 1 diabetes (T1D) as one of the medical conditions associated with…
DiabetesMine: Adjusting Basal (Background) Insulin for Max Impact
“You only need a few days of living with type 1 diabetes (T1D) under your belt to realize just how…
Panel Discussion on Health Inequities in Type 1 Diabetes
We Honor These Words
“Life’s most urgent and persistent question is, What are you doing for others?” – Martin Luther King Jr T1D Exchange…
Tidepool Completes FDA 510(k) Submission of Tidepool Loop
Open Source Diabetes Nonprofit Submits Automated Insulin Dosing App for iPhone for FDA Review Tidepool, a 501(c)3 nonprofit, today announced…
Racial Inequities Among People with Type 1 Diabetes and COVID-19
T1D Exchange is honored to have our recent study results examining racial inequities among people with type 1 diabetes and COVID-19 included in two major publications. Structural and systemic…
JOIN US: The Impact of Virtual Care in T1D
JOIN OUR WEBINAR: “The Impact of Virtual Care in T1D” Learn how telemedicine and remote monitoring are impacting care provided…
